European guidelines for the clinical management and treatment of HIV-infected adults in Europe
- 1 June 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (Supplement) , S3-S26
- https://doi.org/10.1097/00002030-200306002-00002
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European settingAIDS, 2001
- Primary Genotypic and Phenotypic HIV-1 Drug Resistance in Recent Seroconverters in MadridJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Immune control of HIV-1 after early treatment of acute infectionNature, 2000
- Virological and Immunological Effects of Combination Antiretroviral Therapy with Zidovudine, Lamivudine, and Indinavir during Primary Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2000
- Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionAIDS, 2000
- Effect of Combination Antiretroviral Therapy on T‐Cell Immunity in Acute Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2000
- Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug useAIDS, 2000
- Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 TrialThe Journal of Infectious Diseases, 1999
- The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune ResponsesThe Journal of Infectious Diseases, 1999
- A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995